Our Entrance Into SCS Should Be Through Nuvectra. Awesome!

http://www.prnewswire.com/news-releases/soin-neuroscience-commences-a-clinical-case-series-with-nuvectras-algovita-spinal-cord-stimulator-for-back-pain-300611261.html

 

Me too product. Sold entirely on price. all day everyday

 

nice paddle leads. would be easy sells to existing surgeon customers.

 

...and an apparently awesome sacral system hitting sometime Q4 this year or Q1 ‘19. They’ve shown they can grow their business, Stryker is watching closely and I would have to think they like what they are seeing

 

https://www.mddionline.com/nuvectra-suffers-painful-stock-drop-after-regulatory-update

As long as Drees is in charge they will never succeed. You can't sell if your supply chain management and engineering are as bad as Drees has allowed them to become. Drees is a CEO who thinks Engineering is unnecessary after the product is designed. He belongs as a VP of sales and cannot lead a full device company to success.

 

What makes you an expert about Mr Drees’ ability to lead? Those that live in glass houses....

 

based on today's news of his firing, looks like they might have known what they were talking about.

 

Why do you think they fired him? Or that he "stepped down"?